148
Participants
Start Date
August 25, 2020
Primary Completion Date
December 19, 2022
Study Completion Date
December 8, 2023
InterStim Micro
Eligible subjects will receive InterStim Micro therapy. Commercial devices will be used within their intended use as described in each geography's approved instructions for use
Kantonsspital St.Gallen, Sankt Gallen
Montefiore Medical Center, The Bronx
University of Pennsylvania, Philadelphia
West Virginia University, Morgantown
Colon Surgeons of Charleston, Mt. Pleasant
Prisma Health, Greenville
East Coast Institute for Research, Jacksonville
Florida Urology Partners, Tampa
Centre Hospitalier Universitaire De Rennes, Rennes
Vanderbilt University Medical Center, Nashville
University of Louisville Hospital, Louisville
CHU de Nantes - Hôtel Dieu, Nantes
The Christ Hospital, Cincinnati
First Urology, Jeffersonville
Minnesota Urology (Woodbury), Woodbury
Louisiana State University Health Sciences Center New Orleans, New Orleans
Ochsner Medical Center, New Orleans
Urology Partners of North Texas, Arlington
University of Texas Medical Branch, Galveston
Saint Elizabeth Healthcare, Edgewood
University Urology Associates, Toronto
Maastricht Universitair Medisch Centrum (MUMC), Maastricht
Guy's & St Thomas' NHS Foundation Trust - St Thomas' Hospital, London
The Newcastle upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital, Newcastle upon Tyne
Lead Sponsor
MedtronicNeuro
INDUSTRY